Blood test for Alzheimer's biomarkers may speed treatment start
An available blood test was found to identify Alzheimer's patients with and without tau and/or amyloid-beta clumps, needed for treatment.| Alzheimer's News Today
For the first time, scientists have developed a simple, accurate blood test that can potentially identify Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) — a long-term, debilitating condition that affects […] The post Register Today for “From Mystery to Measurable: The Science Behind the New ME/CFS Blood Test” appeared first on Solve ME/CFS Initiative.| Solve ME/CFS Initiative
Lately, more people are told to get a colonoscopy to test for cancer. Not only do colorectal screening tests present a high false positive rate, which ends up being expensive, and causing unnecessary stress, but these screens, and the prescribers, overlook the cause of the polyps. The Tests Over decades, people have come to dread [...]| Nature of Healing
A new University of Florida study aims to determine which of two blood tests can help doctors better track how cervical cancer responds to treatment. Awarded $1.59 million by the Florida Department of Health’s Cancer Innovation Fund and led by Paul Okunieff, MD, professor (shown right), Department of Radiation Oncology, and David Iglesias, MD, chief,…| Radiation Oncology » College of Medicine » University of Florida
An available blood test was found to identify Alzheimer's patients with and without tau and/or amyloid-beta clumps, needed for treatment.| Alzheimer's News Today
Blood levels of two proteins, known as MMP9 and APP, could serve as biomarkers for fragile X syndrome where genetic testing is not possible.| Fragile X News Today
Ampel BioSolutions is launching LuGENE, a lupus blood test that uses AI to look at gene activity to predict flares and personalize treatments.| Lupus News Today
